CD1D and neoplasm: In a primary neuroblastoma without MYC-N amplification, CD1d-expressing CD68+ tumor-associated macrophages (TAMs) stimulate tumor growth through production of IL-6, and a high TAM gene signature is associated with poor prognosis (118).